Skip to content

comparing two method of respiratory support after surfactant administration

Comparison the efficacy of HHFNC Versus NCPAP after Surfactant therapy with INSURE method in preterm infants with respiratory distress syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308283915N9
Enrollment
80
Registered
2013-09-18
Start date
2013-07-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory distress syndrome. Respiratory distress of newborn

Interventions

Treatment - Devices
Intervention 1: Respiratory support by using continuous positive airway pressure ( with positive end expiratory pressure4-6 cm H2o)) started immediately after surfactant replacement therapy in group
Respiratory support by using continuous positive airway pressure ( with positive end expiratory pressure4-6 cm H2o)) started immediately after surfactant replacement therapy in group B
Respiratory support with humidified high flow nasal cannula (2-6 lit/min) started immediately after surfactant replacement therapy in group A

Sponsors

Research Vice Chancellor of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: preterm infants with gestation age 30-35 weeks; admission in NICU with respiratory distress; treatment with surfactant Exclusion criteria: preterm infants with gestation age less than 30 week or above 35 week; intubation immediately after birth before surfactant therapy; respiratory distress score more than 8; severe respiratory distress syndrome in chest x ray.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Need for intubation in first 72 hours. Timepoint: every hour till 2 hours. Method of measurement: clinical assessment.

Secondary

MeasureTime frame
Bronchopulmonary dysplasia. Timepoint: daily till 28 days. Method of measurement: clinically by supplementary oxygen reception.;Duration of hospitalization. Timepoint: daily till discharge. Method of measurement: medical records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactManizheh Mostafa Gharehbaghi

Tabriz University of Medical Sciences

gharehbaghimm@yahoo.com+98 41 1553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026